Browsing by Author "Helvie, Amy E."
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item Previously Unreported Somatic Variants in Two Patients with Pleuropulmonary Blastoma with Metastatic Brain Recurrence(Wiley, 2021) Ferguson, Michael J.; Ivanovich, Jennifer; Stansell, Paige; Vik, Terry A.; Helvie, Amy E.; Schmitt, Morgan R.; Schultz, Kris Ann; Dehner, Louis P.; Renbarger, Jamie L.; Marshall, Mark A.; Pediatrics, School of MedicineItem Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant(Wolters Kluwer, 2020-04-30) Tramontana, Timothy F.; Marshall, Mark S.; Helvie, Amy E.; Schmitt, Morgan R.; Ivanovich, Jennifer; Carter, Jacquelyn L.; Renbarger, Jamie L.; Ferguson, Michael J.; Pediatrics, School of MedicineItem Targeted treatment of refractory primitive neuroectodermal tumor arising from an immature teratoma with crizotinib leading to a sustained response(Wiley, 2023-01-03) Snyder, Benjamin M.; Lion, Alex H.; Helvie, Amy E.; Marshall, Mark S.; Ferguson, Michael J.; Pediatrics, School of MedicineHere we present a case of metastatic PNET which arose from an immature teratoma that was refractory to standard Ewing sarcoma chemotherapy. This PNET was determined to have elevated levels of ALK protein via IHC. The patient was treated with crizotinib on a palliative basis with a sustained response.